Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2024/03/064118
CTRI/2024/03/064118Not yet recruitingPhase 3

A study of The efficacy and safety profile of topical Clindamycin 1% gel versus topical Minocycline 4% gel versus topical Ozenoxacin 1% cream in the treatment of Acne Vulgaris, a triple arm randomized controlled trial - NI

OT APPLICABLE0 sites0 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •All patients with Mild papulopustular Acne fairly localized inflamed and non-inflamed lesions, superficial inflammatory lesions being less than 5mm in diameter according to European evidence based S3 acne guidelines

Exclusion Criteria

  • •Patients with mild comedonal acne
  • •Patients with moderate or severe acne
  • •Patients who have been regularly using anti acne medications since the last 30 days
  • •Patients with acne conglobate, acne fulminans or drug-induced acne
  • •Patients with history of hypersensitivity to clindamycin, minocycline or ozenoxacin
  • •Patients who are unwilling or unable to comply with the study proceedings to give written, informed consent
  • •Pregnant or lactating women
  • •Patients with history of photosensitivity
  • •Hormonal or endocrine or autoimmune abnormality
  • •Topical Steroid Dependent Face

Investigators

Similar Trials

Recruiting
Phase 2
Comparative study between the creams Ozenoxacin and Nadifloxacin in facial Acne
CTRI/2024/01/061760ENDLURU SASIKALA
Not yet recruiting
Not Applicable
A Comparative Study on efficacy and safety of topical 2% clotrimazole cream daily twice application with oral fluconazole and topical 1% Piroctone olamine daily night application with oral fluconazole teice per week for total of 4 weeks in the treatment of extensive dermatophytosis
CTRI/2022/10/046904Department of DV
Recruiting
Phase 4
Study of the effects of two eyedrops, Nepafenac and Flurbiprofen in reducing pain and inflammation in patients who are undergoing cataract surgery.
CTRI/2017/01/007737Dr Saiyadali Allisabanavar80
Not yet recruiting
Phase 3
To compare different drugs like dapsone and clindamycin in patients of Acne Vulgaris over face.
CTRI/2023/11/059725Dr Jyoti Gadhvi
Not yet recruiting
Unknown
Studying the effectiveness of topical blend of herbal extracts in alleviating stress and improving mood in adults.
CTRI/2023/09/057910Sush Essentials Pvt. Ltd